Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | $27.5M | $33M | $7.5M | $8.5M | |
| Gross Profit | -- | $9.5M | $12.4M | $2.7M | $3.8M | |
| Operating Income | -- | -$61.2K | $2.9M | $156.8K | $1.2M | |
| EBITDA | -- | $2.9M | $5.4M | $1M | $1.8M | |
| Diluted EPS | -- | -$0.04 | -$0.02 | -$0.01 | -$0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $8M | $8.9M | |
| Total Assets | -- | -- | -- | $58.6M | $56.2M | |
| Current Liabilities | -- | -- | -- | $16.9M | $7.2M | |
| Total Liabilities | -- | -- | -- | $28.3M | $28.8M | |
| Total Equity | -- | -- | -- | $30.2M | $27.3M | |
| Total Debt | -- | -- | -- | $12.3M | $10.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$31.2K | $2.2M | -$974.8K | $432.4K | |
| Cash From Investing | -- | -$3.9M | $599.7K | -$54.6K | $15K | |
| Cash From Financing | -- | $2.9M | -$2.1M | -$16K | -$316.1K | |
| Free Cash Flow | -- | -$3.9M | $2.1M | -$1M | $422.4K | |
C21 Investments, Inc. engages in the cannabis business. It operates through the Nevada and Corporate geographical segments. It also focuses on the cultivation, processing, and distribution of cannabis and hemp-derived consumer products in the United States. The firm owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a range of tetrahydrocannabinol (THC) and cannabidiol (CBD) products from cannabis flowers and oil, pre-rolls, vaporizer cartridges and edibles. The company was founded on January 15, 1987 and is headquartered in Vancouver, Canada.
In the current month, CXXIF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CXXIF average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that C21 Investments, Inc. share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about C21 Investments, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that C21 Investments, Inc. is a Sell and believe this share price will rise from its current level to --.
The price target for C21 Investments, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for C21 Investments, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of C21 Investments, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase C21 Investments, Inc. shares.
C21 Investments, Inc. was last trading at $0.26 per share. This represents the most recent stock quote for C21 Investments, Inc.. Yesterday, C21 Investments, Inc. closed at $0.32 per share.
In order to purchase C21 Investments, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
With the market starting to look skittish on pure-play AI…
Market Cap: $4.4T
P/E Ratio: 62x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.9T
P/E Ratio: 40x
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.